Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies is a biotech company established in 2017, focused on developing non-addictive pain medications derived from cannabinoids.
- Phytocannabinoids
- Prescription cannabinoid medicines
- Proprietary cannabinoid derivatives
- New chemical entities targeting the endocannabinoid system
Locations
Competitors
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines.
MSD UK is a leading pharmaceutical company dedicated to the discovery and development of innovative medicines and vaccines that improve health outcomes for people and animals.
Company Details
Oxford Cannabinoid Technologies is operated by Oxford Cannabinoid Technologies Ltd and is a Active company incorporated on 10 March 2017 with the registered office located in Cardiff, South Glamorgan. Oxford Cannabinoid Technologies Ltd was registered 8 years ago.
Status
Active
Size
Micro
Directors
4
Age
8 years old
Employees
Unreported
Turnover
Unreported
Total Assets
£10.87K
Cash in Bank
£10.86K
Total Liabilities
-£711.35K
Teams
4
2
1
1
Chief Executive Officer • Joined Apr 2023
Chief Scientific Officer • Joined Jul 2020
Non Executive Chair | NED | Chair ? Audit ? Remuneration ? Committee ? IPO | Flotation | Finance • Joined May 2021
General Counsel & Company Secretary • Joined Dec 2022
Chief Executive Officer • Joined Apr 2023
Chief Scientific Officer • Joined Jul 2020
General Counsel & Company Secretary • Joined Dec 2022
Non Executive Chair | NED | Chair ? Audit ? Remuneration ? Committee ? IPO | Flotation | Finance • Joined May 2021